| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.5 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.079 | 0.5 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | -0.11 | 0.5 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | -0.092 | 0.5 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.5 |